학술논문

Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients
Document Type
Article
Source
In: Trials. (Trials, December 2022, 23(1))
Subject
Language
English
ISSN
17456215